Global Bioinformatics Market – Industry Trends - Forecast to 2026

  • Healthcare IT
  • Upcoming Reports
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Bioinformatics Market By Industry (Molecular Medicine, Drug Development, Clinical Diagnostics, Agriculture, Forensic, Animal, Academics & Research, Environmental, Gene Therapy), Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), Sector (Medical Biotechnology, Academics, Animal  Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology) Application (Preventive Medicine, Molecular Medicine, Genomics, Drug Development, Transcriptomics, Others),  Services (Data Analysis, Sequencing, Database integration, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Bioinformatics Market

Global Bioinformatics Market is expected to reach USD 26.33 billion by 2026 from USD 7.76 billion in 2018, at a CAGR of 16.5% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Definition: Global Bioinformatics Market

A science which is a combination of biology and information technology, connects biological data with techniques for storing information, distributing, and analyzing to support different areas of scientific research, including biomedicine known as Bioinformatics. It applies tools for database creation, data management, data warehousing, data mining, and others. Market Drivers
  • Increasing government initiatives and funding will drive the growth of the market.
  • Growing use of bioinformatics in drug discovery and bio-markers development processes.
Market Restraints
  • Shortage of trained research personnel required for proper use of bioinformatics toolsis expected to act as a restraint to the market growth.
  • Non-availability of platforms to integrate large data sets produced by bioinformatics is expected to offset the growth of this market.

Segmentation: Global Bioinformatics Market

  • By Product Type
    • Sequencing platforms
      • Sequence Analysis Platforms
      • Sequence Alignment Platforms
      • Sequence Manipulation Platforms
      • Structural Analysis Platforms
      • Others
    • Knowledge management tools
      • Generalized Knowledge Management Tools
      • Specialized Knowledge Management Tool
    • Bioinformatics software.
  • By Industry
    • Molecular medicine
    • Drug development
    • Clinical diagnostics
    • Agriculture
    • Forensic
    • Animal
    • Academics and research
    • Environmental and gene therapy
  • By Sector
    • Medical biotechnology
      • Drug discovery & development
      • Clinical diagnostics & precision medicine
      • Reproductive health
    • Academics
    • Animal biotechnology
    • Agricultural biotechnology
    • Environmental biotechnology
    • Forensic biotechnology.
  • By Applications
    • Preventive medicine
    • Molecular medicine
    • Genomics & Drug development
    • Chemoinformatics and drug design
    • Proteomics
    • Transcriptomics
    • Metabolomics
    • Transcriptomics
    • Other biotechnological applications
  • By Services
    • Data integration
    • Data analysis
      • Structural
      • Functional
    • Sequencing
  • By Geography
    • North America
      • US.
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa
Key Developments in the Market:
  • In April 2019, The HANS-GINS Indxx Healthcare Innovation Ucits ETF will focus on developments in sectors including bioinformatics, bioengineering, genome sequencing, healthcare trackers, nanotechnology, neuroscience, robotics and medical devices.
  • In March 2017, Agilent Technologies Inc. introduced its first comparative genomic hybridization (CGH) assay which will be used for diagnostic purposes: the GenetiSureDx Postnatal Assay. This will help the clinical geneticists to detect genetic anomalies early with more accuracy as compared to than traditional methods.

Competitive Analysis: Global Bioinformatics Market

Global bioinformatics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bioinformatics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Bioinformatics Market

Few of the major competitors currently working in the bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc. (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), DNASTAR (US),  Dassault Systèmes (France), DNAnexus, Inc. (US), Genebio (Switzerland), ASEBIO (Spain), PerkinElmer Inc. (US), abm Inc.(Canada) a few among others.

Research Methodology: Global Bioinformatics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry. The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts. Primary Respondents Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others. Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others. Reasons to Purchase this Report
  • Current and future of bioinformatics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL BIOINFORMATICS MARKET
       1.2. CURRENCY AND PRICING
       1.3. LIMITATION
       1.4. MARKETS COVERED

2. MARKET SEGMENTATION

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL BIOINFORMATICS MARKET SIZE
                2.2.1. MARKET CRACKDOWN APPROACH 
                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.2.3. DATA TRIANGULATION
                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
                2.2.6. PORTER’S FIVE FORCES MATRIX
                2.2.7. PEST ANALYSIS
                2.2.8. EPIDEMIOLOGY FORECASTING MODELS
       2.3. GLOBAL BIOINFORMATICS MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET OVERVIEW

       3.1. DRIVERS
       3.2. RESTRAINTS
       3.3. OPPURTUNITIES
       3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL BIOINFORMATICS MARKET, BY INDUSTRY

       6.1. OVERVIEW
       6.2. MOLECULAR MEDICINE
       6.3. DRUG DEVELOPMENT
       6.4. CLINICAL DIAGNOSTICS
       6.5. AGRICULTURE
       6.6. FORENSIC
       6.7. ANIMAL
       6.8. ACADEMICS AND RESEARCH
       6.9. ENVIRONMENTAL
       6.10. GENE THERAPY

7. GLOBAL BIOINFORMATICS  MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW
       7.2. SEQUENCING PLATFORMS
       7.3. KNOWLEDGE MANAGEMENT TOOLS
       7.4. BIOINFORMATICS SOFTWARE

8. GLOBAL BIOINFORMATICS  MARKET, BY SERVICES

       8.1. OVERVIEW
       8.2. DATA ANALYSIS
       8.3. SEQUENCING
       8.4. DATABASE INTEGRATION
       8.5. OTHERS

9. GLOBAL BIOINFORMATICS MARKET, BY APPLICATION

       9.1. OVERVIEW
       9.2. PREVENTIVE MEDICINE
       9.3. MOLECULAR MEDICINE
       9.4. GENOMICS
       9.5. DRUG DEVELOPMENT
       9.6. TRANSCRIPTOMICS
       9.7. OTHERS

10. GLOBAL BIOINFORMATICS MARKET, BY GEOGRAPHY

       10.1. COUNTRYWISE GLOBAL BIOINFORMATICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                  10.1.1. NORTH AMERICA
                               10.1.1.1.  U.S.
                               10.1.1.2. CANADA
                               10.1.1.3.  MEXICO
                  10.1.2. EUROPE
                               10.1.2.1.  GERMANY
                               10.1.2.2.  FRANCE
                               10.1.2.3.  U.K.
                               10.1.2.4.  ITALY
                               10.1.2.5.  SPAIN
                               10.1.2.6.  RUSSIA
                               10.1.2.7.  TURKEY
                               10.1.2.8.  BELGIUM
                               10.1.2.9.  NETHERLANDS
                               10.1.2.10. SWITZERLAND
                               10.1.2.11. REST OF EUROPE
                  10.1.3. ASIA-PACIFIC (APAC)
                               10.1.3.1.      JAPAN
                               10.1.3.2.      CHINA
                               10.1.3.3.      SOUTH KOREA
                               10.1.3.4.      INDIA
                               10.1.3.5.      AUSTRALIA
                               10.1.3.6.      SINGAPORE
                               10.1.3.8.      THAILAND
                               10.1.3.8.      MALAYSIA
                               10.1.3.9.      INDONESIA
                               10.1.3.10.      PHILIPPINES
                               10.1.3.11.      REST OF APAC
                  10.1.4. LATIN AMERICA
                               10.1.4.1.     BRAZIL
                               10.1.4.2.     REST OF LATIN AMERICA
                  10.1.5. MIDDLE EAST AND AFRICA
                               10.1.5.1.     SOUTH AFRICA
                               10.1.5.2.     REST OF MIDDLE EAST AND AFRICA
       10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11. GLOBAL BIOINFORMATICS MARKET: COMPETITIVE LANDSCAPE

       11.1. GLOBAL BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.2. NORTH AMERICA BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.3. EUROPE BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.4. APAC BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.5. MEA BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.6. SOUTH AMERICA BIOINFORMATICS MARKET: COMPANY SHARE ANALYSIS
       11.7. MERGERS & ACQUISITIONS
       11.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       11.9. EXPANSIONS
       11.10. REGULATORY CHANGES
       11.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12. GLOBAL BIOINFORMATICS MARKET, COMPANY PROFILES

       12.1. ILLUMINA, INC.
                  12.1.1. COMPANY OVERVIEW
                  12.1.2. FINANCIAL ANALYSIS
                  12.1.3. PRODUCT MATRIX
                  12.1.4. RECENT DEVELOPMENTS
                  12.1.5. DATABRIDGE ANALYSIS
       12.2. DNANEXUS, INC.
                  12.2.1. COMPANY OVERVIEW
                  12.2.2. FINANCIAL ANALYSIS
                  12.2.3. PRODUCT MATRIX
                  12.2.4. RECENT DEVELOPMENTS
                  12.2.5. DATABRIDGE ANALYSIS
       12.3. QIAGEN
                  12.3.1. COMPANY OVERVIEW
                  12.3.2. FINANCIAL ANALYSIS
                  12.3.3. PRODUCT MATRIX
                  12.3.4. RECENT DEVELOPMENTS
                  12.3.5. DATABRIDGE ANALYSIS
       12.4. THERMO FISHER SCIENTIFIC, INC.
                   12.4.1. COMPANY OVERVIEW
                   12.4.2. FINANCIAL ANALYSIS
                   12.4.3. PRODUCT MATRIX
                   12.4.4. RECENT DEVELOPMENTS
                   12.4.5. DATABRIDGE ANALYSIS
       12.5. AGILENT TECHNOLOGIES
                   12.5.1. COMPANY OVERVIEW
                   12.5.2. FINANCIAL ANALYSIS
                   12.5.3. PRODUCT MATRIX
                   12.5.4. RECENT DEVELOPMENTS
                   12.5.5. DATABRIDGE ANALYSIS
       12.6. DASSAULT SYSTÈMES
                   12.6.1. COMPANY OVERVIEW
                   12.6.2. FINANCIAL ANALYSIS
                   12.6.3. PRODUCT MATRIX
                   12.6.4. RECENT DEVELOPMENTS
                   12.6.5. DATABRIDGE ANALYSIS
       12.7. GENEVA BIOINFORMATICS (GENEBIO) SA
                   12.8.1. COMPANY OVERVIEW
                   12.8.2. FINANCIAL ANALYSIS
                   12.8.3. PRODUCT MATRIX
                   12.8.4. RECENT DEVELOPMENTS
                   12.8.5. DATABRIDGE ANALYSIS
       12.8. INTEGROMICS S.L.
                   12.8.1. COMPANY OVERVIEW
                   12.8.2. FINANCIAL ANALYSIS
                   12.8.3. PRODUCT MATRIX
                   12.8.4. RECENT DEVELOPMENTS
                   12.8.5. DATABRIDGE ANALYSIS
       12.9. PERKINELMER, INC.
                   12.9.1. COMPANY OVERVIEW
                   12.9.2. FINANCIAL ANALYSIS
                   12.9.3. PRODUCT MATRIX
                   12.9.4. RECENT DEVELOPMENTS
                   12.9.5. DATABRIDGE ANALYSIS
       12.10. APPLIED BIOLOGICAL MATERIALS
                     12.10.1. COMPANY OVERVIEW
                     12.10.2. FINANCIAL ANALYSIS
                     12.10.3. PRODUCT MATRIX
                     12.10.4. RECENT DEVELOPMENTS
                     12.10.5. DATABRIDGE ANALYSIS

13. APPENDIX

14. ABOUT DATA BRIDGE MARKET RESEARCH

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART